Literature DB >> 8283604

Insulin-like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy.

T Toyozaki1, M Hiroe, M Hasumi, T Horie, S Hosoda, T Tsushima, M Sekiguchi.   

Abstract

Specific binding sites for insulin-like growth factor I (IGF-I) and their expression during cardiac myocyte hypertrophy were studied by autoradiographic analysis of right ventricular biopsy specimens from patients with hypertrophic cardiomyopathy (9 cases), dilated cardiomyopathy (8 cases), and sick sinus syndrome (5 cases). Frozen specimens were cut into 5 microns-thick sections and thaw-mounted on albumin-coated slides. After incubation with [125I]IGF-I, with or without excess cold IGF-I, autoradiography was performed, and grains over myocytes were counted microscopically. Binding of [125I]IGF-I was inhibited in a dose-dependent manner by unlabeled IGF-I and competed for by IGF-I > IGF-II > insulin. The maximal grain density was higher in hypertrophic cardiomyopathy (186 +/- 47/1.8 x 10(-2) mm2) than in dilated cardiomyopathy (124 +/- 13/1.8 x 10(-2) mm2) or sick sinus syndrome (98 +/- 18/1.8 x 10(-2) mm2) (p < 0.01). There was a strong correlation between the maximal grain density and the diameter of right ventricular myocytes in hypertrophic cardiomyopathy (r = 0.83), but no similar correlation was observed in dilated cardiomyopathy or sick sinus syndrome. These data suggest that IGF-I receptors are present in adult human cardiac myocytes, and that IGF-I receptors are related to the development of myocyte hypertrophy in hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8283604     DOI: 10.1253/jcj.57.1120

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  7 in total

Review 1.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

2.  The effect of insulin-like growth factor-1 on adult rat cardiac contractility.

Authors:  N S Freestone; S Ribaric; W T Mason
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

3.  Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections.

Authors:  A I Günal; A Işik; H Celiker; O Eren; H Celebi; S Y Günal; C Lüleci
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

4.  Relative cardiac expression of growth hormone receptor and insulin-like growth factor-I mRNA in congenital heart disease.

Authors:  A Nygren; J Sunnegårdh; K Albertsson-Wikland; H Berggren; J Isgaard
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

Review 5.  Cardiovascular complications in acromegaly: methods of assessment.

Authors:  G Vitale; R Pivonello; M Galderisi; A D'Errico; L Spinelli; G Lupoli; G Lombardi; A Colao
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

6.  Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R.

Authors:  Wen Yan; Zhi-Chao Dong; Jing-Jing Wang; Yun-Long Zhang; Hong-Xia Wang; Bo Zhang; Hui-Hua Li
Journal:  Front Physiol       Date:  2020-06-09       Impact factor: 4.566

7.  Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart.

Authors:  Yiping Xu; Xuebiao Li; Minjian Kong; Daming Jiang; Aiqiang Dong; Zhonghua Shen; Qunjun Duan
Journal:  Biosci Rep       Date:  2014-10-02       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.